Clinical Trial Update: Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia [Phase 2]

View source ↗

Summary

Phase 2 bone marrow transplant trial for patients with refractory severe aplastic anemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Severe Aplastic Anemia | Phase 2 | Status: TERMINATED